BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 2530586)

  • 1. Wild-type p53 can inhibit oncogene-mediated focus formation.
    Eliyahu D; Michalovitz D; Eliyahu S; Pinhasi-Kimhi O; Oren M
    Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8763-7. PubMed ID: 2530586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear localization is essential for the activity of p53 protein.
    Shaulsky G; Goldfinger N; Tosky MS; Levine AJ; Rotter V
    Oncogene; 1991 Nov; 6(11):2055-65. PubMed ID: 1719467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53-plus-ras-transformed rat embryo fibroblasts express tumor-specific transplantation antigen activity which is shared by independently transformed cells.
    Frey AB; Levine AJ
    J Virol; 1989 Dec; 63(12):5440-4. PubMed ID: 2531235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large E1B proteins of adenovirus types 5 and 12 have different effects on p53 and distinct roles in cell transformation.
    van den Heuvel SJ; van Laar T; The I; van der Eb AJ
    J Virol; 1993 Sep; 67(9):5226-34. PubMed ID: 8350396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The p53 proto-oncogene can act as a suppressor of transformation.
    Finlay CA; Hinds PW; Levine AJ
    Cell; 1989 Jun; 57(7):1083-93. PubMed ID: 2525423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth.
    Finlay CA
    Mol Cell Biol; 1993 Jan; 13(1):301-6. PubMed ID: 8417333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The properties of p53 proteins selected for the loss of suppression of transformation.
    Olson DC; Levine AJ
    Cell Growth Differ; 1994 Jan; 5(1):61-71. PubMed ID: 8123594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The p53 tumor suppressor gene and gene product.
    Levine AJ
    Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A modified p53 overcomes mdm2-mediated oncogenic transformation: a potential cancer therapeutic agent.
    Lin J; Jin X; Page C; Sondak VK; Jiang G; Reynolds RK
    Cancer Res; 2000 Oct; 60(20):5895-901. PubMed ID: 11059788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53.
    Michalovitz D; Halevy O; Oren M
    Cell; 1990 Aug; 62(4):671-80. PubMed ID: 2143698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Participation of p53 cellular tumour antigen in transformation of normal embryonic cells.
    Eliyahu D; Raz A; Gruss P; Givol D; Oren M
    Nature; 1984 Dec 13-19; 312(5995):646-9. PubMed ID: 6095116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation.
    Hinds P; Finlay C; Levine AJ
    J Virol; 1989 Feb; 63(2):739-46. PubMed ID: 2642977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation.
    Parada LF; Land H; Weinberg RA; Wolf D; Rotter V
    Nature; 1984 Dec 13-19; 312(5995):649-51. PubMed ID: 6390217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the cellular p53 and the adenovirus 5 E1B-55kd proteins reduces the oncogenicity of Ad-transformed cells.
    van den Heuvel SJ; van Laar T; Kast WM; Melief CJ; Zantema A; van der Eb AJ
    EMBO J; 1990 Aug; 9(8):2621-9. PubMed ID: 2142453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation.
    Bulavin DV; Tararova ND; Aksenov ND; Pospelov VA; Pospelova TV
    Oncogene; 1999 Oct; 18(41):5611-9. PubMed ID: 10523840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The characteristics of the transformed phenotype and the expression of indicator plasmids in the cells of rat embryonic fibroblasts immortalized by oncogene E1Aad5 and transformed by oncogenes E1Aad5+c-Ha-ras].
    Pospelova TV; Kisliakova TV; Medvedev AV; Svetlikova SB; Pospelov VA
    Tsitologiia; 1990; 32(2):148-55. PubMed ID: 2142348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life.
    Finlay CA; Hinds PW; Tan TH; Eliyahu D; Oren M; Levine AJ
    Mol Cell Biol; 1988 Feb; 8(2):531-9. PubMed ID: 2832726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53.
    Jenkins JR; Rudge K; Currie GA
    Nature; 1984 Dec 13-19; 312(5995):651-4. PubMed ID: 6095117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged inhibition by X-rays of DNA synthesis in cells obtained by transformation of primary rat embryo fibroblasts with oncogenes H-ras and v-myc.
    Wang Y; Iliakis G
    Cancer Res; 1992 Feb; 52(3):508-14. PubMed ID: 1732037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of E1A transfection on MMP-9 expression and metastatic potential.
    Bernhard EJ; Hagner B; Wong C; Lubenski I; Muschel RJ
    Int J Cancer; 1995 Mar; 60(5):718-24. PubMed ID: 7860147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.